Q2 2025 Holdings
Filed 2025-08-14 | 210 holdings | $652.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $71.9M | 5,389,264 | 11.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $52.4M | 948,069 | 8.0% |
| EA Series Trust(BOXX) | ALPHA ARCH 1-3 | 02072L565 | $38.0M | 337,125 | 5.8% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $29.7M | 850,437 | 4.6% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $25.0M | 40,500 | 3.8% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $23.5M | 3,071,340 | 3.6% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $21.9M | 1,940,797 | 3.4% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $20.5M | 3,375,009 | 3.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $19.2M | 582,147 | 2.9% |
| Spdr S&P 500 ETF TR(SPY) | TR UNIT | 78462F103 | $14.0M | 22,684 | 2.1% |
| CG Oncology Inc(CGON) | COM | 156944100 | $13.6M | 523,216 | 2.1% |
| Spdr Series Trust(BIL) | BLOOMBERG 1-3 MO | 78468R663 | $12.4M | 135,585 | 1.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $11.2M | 259,659 | 1.7% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $10.0M | 5,122,105 | 1.5% |
| Septerna Inc(SEPN) | COM | 81734D104 | $9.0M | 847,227 | 1.4% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $8.7M | 2,825,773 | 1.3% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $8.6M | 875,983 | 1.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $8.6M | 535,066 | 1.3% |
| Savara Inc(SVRA) | COM | 805111101 | $8.2M | 3,600,670 | 1.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $8.1M | 259,503 | 1.2% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $8.0M | 1,937,123 | 1.2% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $8.0M | 750,000 | 1.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $7.7M | 1,205,101 | 1.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $7.0M | 3,081,414 | 1.1% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $7.0M | 3,009,870 | 1.1% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $6.6M | 721,599 | 1.0% |
| Rapt Therapeutics Inc(RAPT) | COM NEW | 75382E208 | $6.3M | 783,217 | 1.0% |
| Janux Therapeutics Inc(JANX)Call | COM | 47103J105 | $6.1M | 264,900 | 0.9% |
| AA Mission Acquisition Corp | ORD SHS CL A | G1000R101 | $6.0M | 578,359 | 0.9% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $5.9M | 148,461 | 0.9% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $5.8M | 345,878 | 0.9% |
| Oaktree Acquisition Corp III | UNIT 10/04/2029 | G6717R120 | $5.5M | 516,482 | 0.8% |
| Verve Therapeutics Inc | COM | 92539P101 | $5.3M | 469,018 | 0.8% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $4.9M | 134,136 | 0.8% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $4.7M | 442,615 | 0.7% |
| Ishares TR(SHY) | 1 3 YR TREAS BD | 464287457 | $4.4M | 53,337 | 0.7% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $4.4M | 989,297 | 0.7% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $4.2M | $4,500,000 | 0.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $4.1M | 302,125 | 0.6% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $3.9M | 296,766 | 0.6% |
| Monopar Therapeutics Inc(MNPR) | COM NEW | 61023L207 | $3.6M | 100,974 | 0.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $3.6M | 210,313 | 0.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $3.6M | 915,130 | 0.6% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $3.4M | 622,873 | 0.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $3.2M | 98,032 | 0.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $2.9M | 45,390 | 0.4% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $2.7M | 28,450 | 0.4% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $2.5M | $2,000,000 | 0.4% |
| Alector Inc(ALEC) | COM | 014442107 | $2.4M | 1,723,526 | 0.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $2.4M | 170,598 | 0.4% |